WO2022062011A1 - Method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration - Google Patents
Method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration Download PDFInfo
- Publication number
- WO2022062011A1 WO2022062011A1 PCT/CN2020/122795 CN2020122795W WO2022062011A1 WO 2022062011 A1 WO2022062011 A1 WO 2022062011A1 CN 2020122795 W CN2020122795 W CN 2020122795W WO 2022062011 A1 WO2022062011 A1 WO 2022062011A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrafiltration
- membrane
- tangential flow
- flow rate
- peristaltic pump
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Definitions
- the present invention relates to the field of medical technology, more particularly to the purification of low molecular weight fucosylated glycosaminoglycan compounds.
- Cardiovascular and cerebrovascular diseases have high morbidity, disability, mortality, recurrence and complications, seriously endangering human health and quality of life.
- Thrombosis is one of the main causes of cardiovascular and cerebrovascular diseases.
- Antithrombotic drugs, including anticoagulants, are the first-line clinical drugs for the treatment of cardiovascular and cerebrovascular diseases and occupy an important position in the pharmaceutical market.
- Fucosylated glycosaminoglycans (FG) derived from sea cucumbers are a class of glycosaminoglycan derivatives with fucose side chain substitution, with a main and side chain structure. esterification (J. Biol. Chem., 1996, 271: 23973-23984; Mar. Drugs, 2013, 11: 399-417).
- Naturally derived FG has strong anticoagulant activity (Thromb. Haemost., 2008, 100:420-428; J. Biol. Chem., 1996, 271:23973-23984).
- natural FG still has extensive and contradictory pharmacological effects, including induction of platelet aggregation, bleeding tendency and activation of XII, etc. (Thromb.
- Tangential flow filtration is a widely used separation method in the field of biotechnology, usually used for the concentration, desalination or purification of biological products.
- the liquid flow direction is perpendicular to the filtration direction.
- Substances smaller than the die pore or nominal molecular weight (NMWL) can pass through the membrane, while substances larger than the die pore are generally retained.
- the retention performance of ultrafiltration membrane refers to the retention and permeation performance of the membrane, which is affected by the composition, concentration, tangential flow rate, pressure, etc. of the filtrate.
- the purpose of the present invention is to provide a method for purifying low-molecular-weight fucosylated glycosaminoglycans, using ultrafiltration, a purification method with high efficiency, rapidity, mild conditions and high repeatability, to provide stable, batch-to-batch products for industrial production. Consistent quality ultrafiltration process.
- the concentration range of the crude product after dissolving with purified water is 10-60 mg/ml, preferably 20-40 mg/ml;
- the ultrafiltration membrane package material is regenerated fiber material or polyethersulfone material, and the flow channel is C-type or V-type, wherein regenerated cellulose material is preferred, and the flow channel is preferably V-type. According to the requirements of the product volume, the membrane package can be separately or superimposed;
- the peristaltic pump flow rate is 1 to 5L/min, preferably 2 to 3.5L/min, and during 10kd ultrafiltration, the peristaltic pump flow rate is 1 to 5L/min, preferably 2 to 3.5L/min, and 3kd ultrafiltration.
- the peristaltic pump flow rate is 3 ⁇ 10L/min, preferably 4 ⁇ 7L/min;
- the transmembrane pressure is 0.8 ⁇ 1.2bar, the inlet pressure is 1.0 ⁇ 1.5bar, and the outlet pressure is 0.6 ⁇ 0.9bar;
- water replenishment starts when the volume of the retentate is 1/5 to 1/10 of the total volume, the replenishment volume is 1/5 to 1/10 of the total volume, and the number of replenishment times is 5 to 10 times.
- the entire ultrafiltration process must be carried out in the order of 30kd ⁇ 3kd ⁇ 10kd ⁇ 3kd, and the order cannot be reversed.
- the composition of the low molecular weight fucosylated glycosaminoglycan crude product in the present invention in addition to the low molecular weight fucosylated glycosaminoglycan of the target product, it also contains small molecular inorganic salts, and other macromolecular saccharides, it is difficult to separate and purify using conventional methods, while the tangential flow ultrafiltration because its liquid flow direction is perpendicular to the filtration direction, the viscous macromolecular saccharides are not easy to aggregate on the surface of the membrane envelope, As ultrafiltration progresses, there is no blockage of the membrane cartridges that causes flux to drop, so efficient operation can be maintained all the time.
- ultrafiltration membrane packages with different molecular weight cut-off can be used.
- the interception range of 30kd ultrafiltration membrane package is the substance with molecular weight greater than 30000D
- the interception range of 10kd ultrafiltration membrane package is the substance with molecular weight greater than 10000D
- the cut-off range of the 3kd ultrafiltration membrane package is greater than 3000D molecular weight.
- the present invention adopts three kinds of ultrafiltration membrane packages with different molecular weight cut-offs for ultrafiltration, and through the purification method of controlling parameters such as different crude product concentrations, different transmembrane pressures and pump flow rates, the final product low molecular weight fucosylated glycosamine is obtained.
- the molecular weight of the glycan meets the requirements of 3000-10000 Da, and at the same time, it is efficient, fast, mild in conditions and high in repeatability, and can be used in industrial production.
- the crude product of low molecular weight fucosylated glycosaminoglycan is prepared with reference to the method disclosed in Chinese Patent 201410007855.
- the fucosylated glycosaminoglycan extracted from sea cucumber is used as the starting material, and is subjected to carboxyl esterification, beta elimination and depolymerization. , alkaline hydrolysis deesterification, decolorization, end group reduction and other chemical processes to obtain a crude product of low molecular weight fucosylated glycosaminoglycan, which mainly contains the target product, some large molecular weight heteropolysaccharides that do not undergo depolymerization, inorganic salt etc.
- the crude low molecular weight fucosylated glycosaminoglycan was purified using the following steps:
- the Mw of the sample LGAG-3 obtained in Example 1 is 13709, which has achieved the purpose of separation and purification, but still exceeds the molecular weight requirement range of 3000-10000, and requires further optimization of ultrafiltration conditions.
- the pump flow rate of the 30kd and 10kd ultrafiltration stages has a great influence on the molecular weight, and the small pump flow rate may cause some large molecular weight substances to pass through the membrane package, making the proportion of large molecular weight substances high, and the increase of Mw. Big.
- the crude low molecular weight fucosylated glycosaminoglycan was purified using the following steps:
- the weight-average molecular weight of the purified low-molecular-weight fucosylated glycosaminoglycan is in the range of 3000-10000 Da, and the result of the method meets the requirements of the relevant production technology.
- the weight-average molecular weight of the purified low-molecular-weight fucosylated glycosaminoglycan is in the range of 3000-10000 Da, and the result of the method meets the requirements of the relevant production technology.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Water Supply & Treatment (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Provided is a method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration. The method comprises the following steps: (1) dissolving a crude product in a certain proportion of water, and filtering same to obtain a mother solution; (2) installing a 30 kd membrane bag ultrafiltration system, and carrying out ultrafiltration on the mother solution, and then collecting the ultrafiltrate; (3) carrying out ultrafiltration by using a 3 kd membrane bag ultrafiltration system to remove small molecule organic and inorganic matter, and sampling trapped fluid; (4) carrying out ultrafiltration by using a 10 kd membrane ultrafiltration system, and collecting a percolate; and (5) finally, carrying out concentration by using the 3 kd membrane ultrafiltration system. The method provided by the invention has the advantages of a high efficiency, rapidness, mild conditions and a high repeatability, and provides a stable ultrafiltration process with a consistent product quality between batches for industrial production.
Description
本发明涉及医药技术领域领域,更具体为低分子量岩藻糖化糖胺聚糖类化合物的纯化。The present invention relates to the field of medical technology, more particularly to the purification of low molecular weight fucosylated glycosaminoglycan compounds.
心脑血管疾病的发病率高、致残率高、死亡率高、复发率高和并发症高,严重危害人类的健康和生活质量。血栓形成是心脑血管疾病的主要病因之一,包括抗凝药物在内的抗血栓药物是心脑血管疾病治疗的临床一线用药,在医药市场上占有重要地位。目前国内外对于抗凝药物的研究依旧如火如荼,开发出了一代又一代副作用低、抗凝效果好的药物,比如阿派沙班、利伐沙班、达比加群酯、肝素钠、依诺肝素钠等药物,但是此类药物的缺陷主要是与靶点相关的严重出血风险和血小板减少症等。因此,临床需要具有优势药理药效作用特点的新型抗凝药物。新型抗凝血药物研发的核心是有效避免出血倾向,而低出血倾向的创新药物研究尚未取得突破进展。Cardiovascular and cerebrovascular diseases have high morbidity, disability, mortality, recurrence and complications, seriously endangering human health and quality of life. Thrombosis is one of the main causes of cardiovascular and cerebrovascular diseases. Antithrombotic drugs, including anticoagulants, are the first-line clinical drugs for the treatment of cardiovascular and cerebrovascular diseases and occupy an important position in the pharmaceutical market. At present, the research on anticoagulant drugs at home and abroad is still in full swing, and generations of drugs with low side effects and good anticoagulant effects have been developed, such as apixaban, rivaroxaban, dabigatran etexilate, heparin sodium, enol Drugs such as heparin sodium, but the defects of such drugs are mainly the risk of severe bleeding and thrombocytopenia related to the target. Therefore, there is a need for new anticoagulant drugs with superior pharmacological and pharmacodynamic characteristics. The core of the research and development of new anticoagulant drugs is to effectively avoid bleeding tendency, while the research on innovative drugs with low bleeding tendency has not yet made a breakthrough.
海参类动物来源的岩藻糖化糖胺聚糖(FG)是一类具有岩藻糖侧链取代的糖胺聚糖类衍生物,具有主侧链结构,同时主侧链均被硫酸基不同程度的酯化(J.Biol.Chem.,1996,271:23973-23984;Mar.Drugs,2013,11:399-417)。天然来源的FG具有很强的抗凝活性(Thromb.Haemost.,2008,100:420-428;J.Biol.Chem.,1996,271:23973-23984)。然而,天然FG仍存在广泛而矛盾的药理作用,包括诱导血小板聚集、产生出血倾向和激活XII等(Thromb.Haemost.,1988,59:432-434;Thromb.Haemost.,1997,65(4):369-373)。通过化学手段适当解聚后,可以获得低分子量的岩藻糖化糖胺聚糖,但是如何将该低分子量的岩藻糖化糖胺聚糖与其它小分子盐类、未解聚及部分解聚的大分子岩藻糖化糖胺聚糖等物质分开,目前未见报道,因此本发明提供了一种纯化低分子量的岩藻糖化糖胺聚糖的方法。Fucosylated glycosaminoglycans (FG) derived from sea cucumbers are a class of glycosaminoglycan derivatives with fucose side chain substitution, with a main and side chain structure. esterification (J. Biol. Chem., 1996, 271: 23973-23984; Mar. Drugs, 2013, 11: 399-417). Naturally derived FG has strong anticoagulant activity (Thromb. Haemost., 2008, 100:420-428; J. Biol. Chem., 1996, 271:23973-23984). However, natural FG still has extensive and contradictory pharmacological effects, including induction of platelet aggregation, bleeding tendency and activation of XII, etc. (Thromb. Haemost., 1988, 59: 432-434; Thromb. Haemost., 1997, 65(4) : 369-373). After proper depolymerization by chemical means, low-molecular-weight fucosylated glycosaminoglycans can be obtained. The separation of macromolecular fucosylated glycosaminoglycans and other substances has not been reported so far, so the present invention provides a method for purifying low molecular weight fucosylated glycosaminoglycans.
切向流过滤是一种生物技术领域应用广泛的分离方法,通常用于生物制品的浓缩、脱盐或纯化。在切向流过滤过程中,液体流动方向与过滤方向呈垂直方向,小于模孔或名义分子量(NMWL)的物质可以透过膜,而大于模孔的物 质一般被截留。超滤膜的截留性能是指对膜的截留和透过性能,受到滤液的成分,浓度,切向流速,压力等的影响。Tangential flow filtration is a widely used separation method in the field of biotechnology, usually used for the concentration, desalination or purification of biological products. In the tangential flow filtration process, the liquid flow direction is perpendicular to the filtration direction. Substances smaller than the die pore or nominal molecular weight (NMWL) can pass through the membrane, while substances larger than the die pore are generally retained. The retention performance of ultrafiltration membrane refers to the retention and permeation performance of the membrane, which is affected by the composition, concentration, tangential flow rate, pressure, etc. of the filtrate.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种纯化低分子量的岩藻糖化糖胺聚糖的方法,采用超滤这种高效快速、条件温和、可重复性高的纯化手段,为工业化生产提供稳定、批间产品质量一致的超滤工艺。The purpose of the present invention is to provide a method for purifying low-molecular-weight fucosylated glycosaminoglycans, using ultrafiltration, a purification method with high efficiency, rapidity, mild conditions and high repeatability, to provide stable, batch-to-batch products for industrial production. Consistent quality ultrafiltration process.
为实现上述目的,本发明采用的技术方案如下:For achieving the above object, the technical scheme adopted in the present invention is as follows:
(1)将经过半合成得到的低分子量岩藻糖化糖胺聚糖粗产物使用一定比例的纯化水溶解,分别通过1μm、0.45μm滤芯过滤后,得到超滤母液;(1) Dissolving the low molecular weight fucosylated glycosaminoglycan crude product obtained by semi-synthesis in a certain proportion of purified water, and filtering through 1 μm and 0.45 μm filter elements, respectively, to obtain an ultrafiltration mother liquor;
(2)安装超滤系统:从保护液中取出30kd超滤膜包,安装于夹具中间夹紧,连接好管路,先使用少量纯化水清洗,再用0.1M NaOH循环30min,然后用纯化水洗至中性,气密性测试合格后,打开蠕动泵调至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,到一定体积后补水3~6次,合并所有透过液;(2) Install the ultrafiltration system: take out the 30kd ultrafiltration membrane package from the protective solution, install it in the middle of the fixture and clamp it, connect the pipeline, first wash it with a small amount of purified water, then circulate it with 0.1M NaOH for 30min, and then wash it with purified water After reaching neutrality and passing the air tightness test, turn on the peristaltic pump and adjust the flow rate to a certain flow rate, adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements, start ultrafiltration, and replenish water 3-6 times after reaching a certain volume, and combine all the permeation liquid;
(2)更换3kd超滤膜包,从保护液中取出3kd超滤膜包,安装于夹具中间夹紧,连接好管路,先使用少量纯化水清洗,再用0.1M NaOH循环30min,然后用纯化水洗至中性,测试气密性,合格后调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,超滤至剩余一定体积后补水,直至检测盐含量合格后停止超滤,收集截留液;(2) Replace the 3kd ultrafiltration membrane package, take out the 3kd ultrafiltration membrane package from the protective solution, install it in the middle of the fixture and clamp it, connect the pipeline, first wash with a small amount of purified water, and then circulate it with 0.1M NaOH for 30min, and then use Wash the purified water to neutrality, test the air tightness, adjust the speed of the peristaltic pump to a certain flow rate after passing the test, adjust the inlet and outlet pressure to make the transmembrane pressure meet the requirements, start ultrafiltration, and add water after ultrafiltration to a certain volume remaining until the salt is detected. After the content is qualified, the ultrafiltration is stopped, and the retentate is collected;
(3)更换10kd超滤膜包,,从保护液中取出10kd超滤膜包,安装于夹具中间夹紧,连接好管路,先使用少量纯化水清洗,再用0.1M NaOH循环30min,然后用纯化水洗至中性,气密性测试合格后调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤并收集透过液,超滤至一定体积后补水3~6次,合并所有透过液;(3) Replace the 10kd ultrafiltration membrane package, take out the 10kd ultrafiltration membrane package from the protective solution, install it in the middle of the fixture and clamp it, connect the pipeline, first wash with a small amount of purified water, and then circulate it with 0.1M NaOH for 30min, then Wash with purified water to neutrality. After passing the air tightness test, adjust the speed of the peristaltic pump to a certain flow rate, adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements, start ultrafiltration and collect the permeate, and add water after ultrafiltration to a certain volume. 3-6 times, combine all the permeate;
(4)3kd超滤浓缩,从保护液中取出10kd超滤膜包,安装于夹具中间夹紧,连接好管路,先使用少量纯化水清洗,再用0.1M NaOH循环30min,然后用纯化水洗至中性,气密性测试合格后,调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,超滤至剩余一定体积后停止,放出截留液,少量水冲洗膜包及管路,与截留液合并,进行冷冻干燥;(4) 3kd ultrafiltration and concentration, take out the 10kd ultrafiltration membrane package from the protective solution, install it in the middle of the clamp and clamp it, connect the pipeline, first wash with a small amount of purified water, then circulate with 0.1M NaOH for 30min, and then wash with purified water To neutrality, after passing the air tightness test, adjust the speed of the peristaltic pump to a certain flow rate, adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements, start ultrafiltration, stop after ultrafiltration to a certain volume remaining, and release the retentate, a small amount Rinse the membrane package and pipeline with water, combine with the retentate, and freeze-dry;
(5)检测其分子量及无机盐等小分子杂质。(5) Detect its molecular weight and small molecular impurities such as inorganic salts.
本发明方法中,粗产物用纯化水溶解后的浓度范围为10~60mg/ml,优选20~40mg/ml;In the method of the present invention, the concentration range of the crude product after dissolving with purified water is 10-60 mg/ml, preferably 20-40 mg/ml;
所述的超滤膜包材质为再生纤维材质或聚醚砜材质,流道为C型或V型,其中优选再生纤维素材质,流道优选V型,根据产物量的要求,膜包可以单独或叠加使用;The ultrafiltration membrane package material is regenerated fiber material or polyethersulfone material, and the flow channel is C-type or V-type, wherein regenerated cellulose material is preferred, and the flow channel is preferably V-type. According to the requirements of the product volume, the membrane package can be separately or superimposed;
30kd超滤时蠕动泵流速为1~5L/min,优选2~3.5L/min,10kd超滤时超滤时蠕动泵流速为1~5L/min,优选2~3.5L/min,,3kd超滤时蠕动泵流速为3~10L/min,优选4~7L/min;跨膜压为0.8~1.2bar,进口压为1.0~1.5bar,出口压为0.6~0.9bar;During 30kd ultrafiltration, the peristaltic pump flow rate is 1 to 5L/min, preferably 2 to 3.5L/min, and during 10kd ultrafiltration, the peristaltic pump flow rate is 1 to 5L/min, preferably 2 to 3.5L/min, and 3kd ultrafiltration. During filtration, the peristaltic pump flow rate is 3~10L/min, preferably 4~7L/min; the transmembrane pressure is 0.8~1.2bar, the inlet pressure is 1.0~1.5bar, and the outlet pressure is 0.6~0.9bar;
3kd超滤去除小分子杂质过程中,截留液体积为总体积的1/5~1/10时开始补水,补水体积为总体积的1/5~1/10,补水次数为5~10次。In the process of removing small molecular impurities by 3kd ultrafiltration, water replenishment starts when the volume of the retentate is 1/5 to 1/10 of the total volume, the replenishment volume is 1/5 to 1/10 of the total volume, and the number of replenishment times is 5 to 10 times.
整个超滤过程须按照30kd→3kd→10kd→3kd的顺序进行,不能颠倒顺序。The entire ultrafiltration process must be carried out in the order of 30kd→3kd→10kd→3kd, and the order cannot be reversed.
糖类物质由于其本身的粘性,以及本发明中低分子量岩藻糖化糖胺聚糖粗产物的组成中除了目标产物低分子量的岩藻糖化糖胺聚糖,还含有小分子的无机盐类,和其他大分子的糖类,使用常规方法难以进行分离纯化,而切向流超滤由于其液体流动方向与过滤方向呈垂直,使得粘性较大的大分子的糖类不易聚集于膜包表面,随着超滤的进行也不会堵塞膜包而造成通量下降,因此可以一直保持高效运行。根据目标分子量的不同以及杂质的组成,可采用不同截留分子量的超滤膜包,30kd超滤膜包的截留范围为大于30000D分子量的物质,10kd超滤膜包的截留范围为大于10000D分子量的物质,而3kd超滤膜包的截留范围为大于3000D分子量的物质。Due to its own viscosity, and the composition of the low molecular weight fucosylated glycosaminoglycan crude product in the present invention, in addition to the low molecular weight fucosylated glycosaminoglycan of the target product, it also contains small molecular inorganic salts, and other macromolecular saccharides, it is difficult to separate and purify using conventional methods, while the tangential flow ultrafiltration because its liquid flow direction is perpendicular to the filtration direction, the viscous macromolecular saccharides are not easy to aggregate on the surface of the membrane envelope, As ultrafiltration progresses, there is no blockage of the membrane cartridges that causes flux to drop, so efficient operation can be maintained all the time. According to the difference of target molecular weight and the composition of impurities, ultrafiltration membrane packages with different molecular weight cut-off can be used. The interception range of 30kd ultrafiltration membrane package is the substance with molecular weight greater than 30000D, and the interception range of 10kd ultrafiltration membrane package is the substance with molecular weight greater than 10000D , while the cut-off range of the 3kd ultrafiltration membrane package is greater than 3000D molecular weight.
本发明采用三种不同截留分子量的超滤膜包进行超滤,并且通过控制不同的粗产物浓度、不同的跨膜压及泵流速等参数的纯化方法,使最终产物低分子量岩藻糖化糖胺聚糖的分子量符合3000~10000Da要求,同时高效快速、条件温和、可重复性高,可以用于工业化生产。The present invention adopts three kinds of ultrafiltration membrane packages with different molecular weight cut-offs for ultrafiltration, and through the purification method of controlling parameters such as different crude product concentrations, different transmembrane pressures and pump flow rates, the final product low molecular weight fucosylated glycosamine is obtained. The molecular weight of the glycan meets the requirements of 3000-10000 Da, and at the same time, it is efficient, fast, mild in conditions and high in repeatability, and can be used in industrial production.
根据下述实施例,可以更好的理解本发明。然而,本领域的技术人员容易理解,实施例所描述的内容仅用于说明本发明的具体实施方式,而不应当也不 会对本发明的范围有所限制。The present invention can be better understood from the following examples. However, those skilled in the art can easily understand that the content described in the embodiments is only used to illustrate the specific embodiments of the present invention, and should not and will not limit the scope of the present invention.
材料和试剂Materials and Reagents
低分子量岩藻糖化糖胺聚糖粗产物,是参考中国专利201410007855公开的方法制备方法,以海参中提取得到的岩藻糖化糖胺聚糖为起始原料,经过羧基酯化、β消除解聚、碱解脱酯、脱色、端基还原等一系列化学过程得到了低分子量岩藻糖化糖胺聚糖粗产物,该粗产物中主要包含目标产物、部分不发生解聚的大分子量杂多糖、无机盐等。The crude product of low molecular weight fucosylated glycosaminoglycan is prepared with reference to the method disclosed in Chinese Patent 201410007855. The fucosylated glycosaminoglycan extracted from sea cucumber is used as the starting material, and is subjected to carboxyl esterification, beta elimination and depolymerization. , alkaline hydrolysis deesterification, decolorization, end group reduction and other chemical processes to obtain a crude product of low molecular weight fucosylated glycosaminoglycan, which mainly contains the target product, some large molecular weight heteropolysaccharides that do not undergo depolymerization, inorganic salt etc.
30kd、10kd、3kd超滤膜包及蠕动泵均购买自密理博,0.5㎡,氢氧化钠为市售分析纯,购自北京化工厂;纯化水为车间自制。30kd, 10kd, 3kd ultrafiltration membrane packs and peristaltic pumps were purchased from Millipore, 0.5 square meters, sodium hydroxide was commercially available analytical grade, purchased from Beijing Chemical Factory; purified water was made by the workshop.
实施例1Example 1
采用以下步骤对低分子量岩藻糖化糖胺聚糖粗产物进行纯化:The crude low molecular weight fucosylated glycosaminoglycan was purified using the following steps:
(1)粗产物加入纯化水15L,浓度约为28mg/ml,分别过1μm、0.45μm滤膜,此处过滤的目的为除掉部分外来引入的不溶性微粒等,以防止损坏或堵塞膜包,故过滤前后的初始浓度无变化。冲洗过滤系统共得到滤液约23L,进行超滤。(1) Add 15 L of purified water to the crude product, the concentration is about 28 mg/ml, and pass through 1 μm and 0.45 μm filter membranes respectively. The purpose of filtration here is to remove some insoluble particles introduced from outside, so as to prevent damage or blockage of the membrane package, Therefore, the initial concentration before and after filtration did not change. A total of about 23L of filtrate was obtained by washing the filtration system, and ultrafiltration was carried out.
(2)取30kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,气密性良好,开始超滤样品。出口压0.8bar,进口压0.8、1.0bar,泵流速1.2L/min,超滤至约1L后补水,每次2.5L,共6次,合并透过液约38L。超滤结束后水清洗、0.1N氢氧化钠溶液膜包,结束超滤。(2) Take a 30kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane package with 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral and has good air tightness, and starts ultrafiltration. sample. The outlet pressure is 0.8bar, the inlet pressure is 0.8, 1.0bar, the pump flow rate is 1.2L/min, and the water is replenished after ultrafiltration to about 1L, 2.5L each time, a total of 6 times, and the combined permeate is about 38L. After the ultrafiltration, wash with water, pack with 0.1N sodium hydroxide solution membrane, and end the ultrafiltration.
(3)取3kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.0bar,进口压1.2bar,泵流速3.9L/min,超滤至5L时开始补水,每次5L,通过AgNO
3检测透过端直至无Cl
-残留,结束超滤,稀释截留液至18L。
(3) Take a 3kd regenerated cellulose membrane pack, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane pack with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and the air tightness is good. Start Ultrafiltration sample, the outlet pressure is 1.0bar, the inlet pressure is 1.2bar, the pump flow rate is 3.9L/min, and the water is replenished when the ultrafiltration reaches 5L, 5L each time, and the permeating end is detected by AgNO 3 until there is no Cl- residue, and the ultrafiltration is ended. Dilute the retentate to 18L.
(4)取10kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压0.7bar,进口压1.1bar,泵流速1.2L/min,超滤至1.0L,然后补水2.5L,共补水6次,合并所有透过液。(4) Take a 10kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and then rinse the membrane package with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 0.7bar, inlet pressure 1.1bar, pump flow rate 1.2L/min, ultrafiltered to 1.0L, and then replenished with 2.5L of water for a total of 6 times, and combined all the permeate.
(5)取3kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.1bar,进口压1.3bar,泵流速4.0L/min,超滤至1.5L时停止超滤,用500ml×3次纯化水冲洗膜包及管路,合并截留液,过0.22μm滤膜,然后冻干。(5) Take a 3kd regenerated cellulose membrane pack, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane pack with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 1.1bar, inlet pressure 1.3bar, pump flow rate 4.0L/min, stop ultrafiltration when ultrafiltration reaches 1.5L, rinse membrane capsule and pipeline with 500ml×3 times of purified water, combine retentate, filter 0.22 μm filter, then lyophilized.
(6)HPLC检测冻干产物的重均分子量,结果如下:(6) HPLC detects the weight-average molecular weight of the freeze-dried product, and the results are as follows:
本实施例1中得到的样品LGAG-3的Mw为13709,已经达到了分离纯化的目的,但是仍超出3000-10000的分子量要求范围,需要进一步优化超滤条件。通过前期研究发现,30kd及10kd超滤阶段的泵流速对分子量影响较大,泵流速偏小可能会造成部分大分子量的物质透过膜包,使得大分子量物质的比例偏高,以及Mw的增大。The Mw of the sample LGAG-3 obtained in Example 1 is 13709, which has achieved the purpose of separation and purification, but still exceeds the molecular weight requirement range of 3000-10000, and requires further optimization of ultrafiltration conditions. Through the previous research, it was found that the pump flow rate of the 30kd and 10kd ultrafiltration stages has a great influence on the molecular weight, and the small pump flow rate may cause some large molecular weight substances to pass through the membrane package, making the proportion of large molecular weight substances high, and the increase of Mw. Big.
实施例2Example 2
采用以下步骤对低分子量岩藻糖化糖胺聚糖粗产物进行纯化:The crude low molecular weight fucosylated glycosaminoglycan was purified using the following steps:
(1)粗产物加入纯化水22L,分别过1μm、0.45μm滤膜,冲洗过滤系统共得到滤液约33L,浓度为36mg/ml。(1) Add 22 L of purified water to the crude product, pass through 1 μm and 0.45 μm filter membranes respectively, and rinse the filtration system to obtain a total of about 33 L of filtrate with a concentration of 36 mg/ml.
(2)取30kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,气密性良好,开始超滤粗产物样品。出口压0.8bar,进口压1.2bar,泵流速2.3L/min,超滤至约1.5L后补水,每次3.6L,共6次,合并透过液约54L。超滤结束后水清洗、0.1M氢氧化钠溶液膜包,结束超滤。(2) Take a 30kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane package with 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral and has good air tightness, and starts ultrafiltration. Crude product sample. The outlet pressure is 0.8bar, the inlet pressure is 1.2bar, the pump flow rate is 2.3L/min, and the water is replenished after ultrafiltration to about 1.5L, 3.6L each time, a total of 6 times, and the combined permeate is about 54L. After the ultrafiltration, wash with water, pack with 0.1M sodium hydroxide solution membrane, and end the ultrafiltration.
(3)取3kd再生纤维素膜包两块,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.0bar,进口压1.2bar,泵流速3.5L/min,超滤至5L时开始补水,每次5L,通过AgNO
3检测透过端直至无Cl
-残留,结束超滤,稀释截留液至22L。
(3) Take two 3kd regenerated cellulose membrane packs, install the ultrafiltration equipment, rinse with 10L of purified water for 10 minutes, and then rinse the membrane packs with 10L of 0.1M sodium hydroxide solution for 30 minutes, then wash with water until neutral, and the air tightness is good. , start the ultrafiltration of the sample, the outlet pressure is 1.0bar, the inlet pressure is 1.2bar, the pump flow rate is 3.5L/min, and the water is replenished when the ultrafiltration reaches 5L, each 5L, and the permeating end is detected by AgNO 3 until there is no Cl- residue, and the ultrafiltration is over. Filter and dilute the retentate to 22L.
(4)取10kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压0.8bar,进口压1.1bar,泵流速2.3L/min,超滤至1.5L,然后补水3.6L,共补水6次,合并所有透过液。(4) Take a 10kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and then rinse the membrane package with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 0.8bar, inlet pressure 1.1bar, pump flow rate 2.3L/min, ultrafiltration to 1.5L, and then replenishing 3.6L of water for a total of 6 times, and combining all the permeate.
(5)取3kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.0bar,进口压1.2bar,泵流速3.5L/min,超滤至1.5L时停止超滤,用500ml×3次纯化水冲洗膜包及管路,合并截留液,过0.22μm滤膜,然后冻干。(5) Take a 3kd regenerated cellulose membrane pack, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane pack with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 1.0bar, inlet pressure 1.2bar, pump flow rate 3.5L/min, stop ultrafiltration when ultrafiltration reaches 1.5L, rinse the membrane package and pipeline with 500ml×3 times of purified water, combine the retentate, filter 0.22 μm filter, then lyophilized.
(6)HPLC检测经过纯化的低分子量岩藻糖化糖胺聚糖的重均分子量,结果如下:(6) HPLC detects the weight-average molecular weight of the purified low-molecular-weight fucosylated glycosaminoglycan, and the results are as follows:
经过纯化的低分子量岩藻糖化糖胺聚糖的重均分子量在3000~10000Da范围内,该方法的结果符合相关生产工艺要求。The weight-average molecular weight of the purified low-molecular-weight fucosylated glycosaminoglycan is in the range of 3000-10000 Da, and the result of the method meets the requirements of the relevant production technology.
实施例3Example 3
采用以下步骤对低分子量岩藻糖化糖胺聚糖粗产物进行纯化The following steps were used to purify the crude low molecular weight fucosylated glycosaminoglycan
(1)粗产物加入纯化水18L,过1μm、0.45μm滤膜,冲洗过滤系统共得到滤液约23L,浓度为25mg/ml。(1) Add 18 L of purified water to the crude product, pass through a 1 μm and 0.45 μm filter membrane, and rinse the filtration system to obtain a total of about 23 L of filtrate with a concentration of 25 mg/ml.
(2)取30kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,气密性良好,开始超滤样品。出口压0.7bar,进口压1.4bar,泵流速2.7L/min,超滤至约1.5L后补水,每次3.6L,共6次,合并透过液约45L。超滤结束后水清洗、0.1MN氢氧化钠溶液膜包,结束超滤。(2) Take a 30kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane package with 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral and has good air tightness, and starts ultrafiltration. sample. The outlet pressure is 0.7bar, the inlet pressure is 1.4bar, the pump flow rate is 2.7L/min, and the water is replenished after ultrafiltration to about 1.5L, 3.6L each time, a total of 6 times, and the combined permeate is about 45L. After the ultrafiltration, wash with water, pack with 0.1MN sodium hydroxide solution membrane, and end the ultrafiltration.
(3)取3kd再生纤维素膜包两块,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.1bar,进口压1.3bar,泵流速4.0L/min,超滤 至5L时开始补水,每次5L,通过AgNO
3检测透过端直至无Cl
-残留,结束超滤,稀释截留液至18L。
(3) Take two 3kd regenerated cellulose membrane packs, install the ultrafiltration equipment, rinse with 10L of purified water for 10 minutes, and then rinse the membrane packs with 10L of 0.1M sodium hydroxide solution for 30 minutes, then wash with water until neutral, and the air tightness is good. , start the ultrafiltration of the sample, the outlet pressure is 1.1bar, the inlet pressure is 1.3bar, the pump flow rate is 4.0L/min, and the water is replenished when the ultrafiltration reaches 5L, 5L each time, and the permeating end is detected by AgNO 3 until there is no Cl- residue, and the ultrafiltration is over. Filter and dilute the retentate to 18L.
(4)取10kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压0.6bar,进口压1.3bar,泵流速2.9L,超滤至1.5L,然后补水3.6L,共补水6次,合并所有透过液。(4) Take a 10kd regenerated cellulose membrane package, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and then rinse the membrane package with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 0.6bar, inlet pressure 1.3bar, pump flow rate 2.9L, ultrafiltered to 1.5L, and then replenished with 3.6L of water, a total of 6 times of water, and combined all the permeate.
(5)取3kd再生纤维素膜包,安装好超滤设备,10L纯化水冲洗10min后,10L 0.1M氢氧化钠溶液回流冲洗膜包30min,然后水洗至中性,测试气密性良好,开始超滤样品,出口压1.1bar,进口压1.3bar,泵流速4.0L/min,超滤至1.5L时停止超滤,用500ml×3次纯化水冲洗膜包及管路,合并截留液,过0.22μm滤膜,然后冻干。(5) Take a 3kd regenerated cellulose membrane pack, install the ultrafiltration equipment, rinse with 10L purified water for 10 minutes, and rinse the membrane pack with 10L 0.1M sodium hydroxide solution for 30 minutes, then wash it with water until it is neutral, and test the air tightness. Ultrafiltration sample, outlet pressure 1.1bar, inlet pressure 1.3bar, pump flow rate 4.0L/min, stop ultrafiltration when ultrafiltration reaches 1.5L, rinse membrane capsule and pipeline with 500ml×3 times of purified water, combine retentate, filter 0.22 μm filter, then lyophilized.
(6)HPLC检测其重均分子量,结果如下:(6) HPLC detects its weight-average molecular weight, and the results are as follows:
经过纯化的低分子量岩藻糖化糖胺聚糖的重均分子量在3000~10000Da范围内,该方法的结果符合相关生产工艺要求。The weight-average molecular weight of the purified low-molecular-weight fucosylated glycosaminoglycan is in the range of 3000-10000 Da, and the result of the method meets the requirements of the relevant production technology.
Claims (10)
- 一种使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,包括以下步骤:A method for purifying low molecular weight fucosylated glycosaminoglycans using tangential flow ultrafiltration, comprising the following steps:(1)低分子量岩藻糖化糖胺聚糖粗产物使用纯化水溶解,分别过1μm、0.45μm滤芯超滤得到母液;(1) The crude product of low molecular weight fucosylated glycosaminoglycan was dissolved in purified water, and the mother liquor was obtained by ultrafiltration through 1 μm and 0.45 μm filter elements respectively;(2)使用安装有30kd超滤膜包的超滤系统对步骤(1)得到的母液进行切向流超滤,收集透过液;(2) use the ultrafiltration system installed with the 30kd ultrafiltration membrane package to carry out tangential flow ultrafiltration to the mother liquor obtained in step (1), and collect the permeate;(3)使用安装有3kd超滤膜包的超滤系统对步骤(2)收集的透过液进行切向流超滤,收集截留液;(3) use the ultrafiltration system installed with the 3kd ultrafiltration membrane package to carry out tangential flow ultrafiltration to the permeate collected in step (2), and collect the retentate;(4)使用安装有10kd超滤膜包的超滤系统对步骤(3)收集的截留液进行切向流超滤,收集透过液;(4) use the ultrafiltration system installed with 10kd ultrafiltration membrane package to carry out tangential flow ultrafiltration to the retentate collected in step (3), and collect permeate;(5)使用安装有3kd超滤膜包的超滤系统对步骤(4)收集的透过液进行切向流超滤,收集截留液,即为纯化后的低分子量岩藻糖化糖胺聚糖。(5) Use an ultrafiltration system equipped with a 3kd ultrafiltration membrane package to perform tangential flow ultrafiltration on the permeate collected in step (4), and collect the retentate, which is the purified low molecular weight fucosylated glycosaminoglycan .
- 根据权利要求1所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,所述低分子量岩藻糖化糖胺聚糖粗产物纯化水溶解后的浓度范围为10~60mg/ml。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 1, wherein the concentration range of the low-molecular-weight fucosylated glycosaminoglycan crude product after dissolving in purified water It is 10~60mg/ml.
- 根据权利要求1所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,所述的超滤膜包材质为再生纤维材质或聚醚砜材质,流道为C型或V型。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 1, wherein the ultrafiltration membrane package material is regenerated fiber material or polyethersulfone material, and the flow channel Type C or V.
- 根据权利要求1所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于:The method for purifying low molecular weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 1, wherein:所述步骤(2)为将30kd超滤膜包置于夹具中间安装超滤系统,连接管路,气密性测试合格后,打开蠕动泵调至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,超滤至一定体积后补水3~6次,合并收集所有透过液;The step (2) is to place the 30kd ultrafiltration membrane package in the middle of the fixture to install an ultrafiltration system, connect the pipeline, and after the air tightness test is qualified, turn on the peristaltic pump and adjust to a certain flow rate, adjust the inlet and outlet pressures, and make the membrane across the membrane. When the pressure meets the requirements, start ultrafiltration, and after ultrafiltration to a certain volume, add water for 3 to 6 times, and collect all the permeate together;所述步骤(3)为,将超滤系统更换为3kd超滤膜包,安装好后测试气密性,合格后调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,超滤至剩余一定体积后补水,检测透过端滤液直至无Cl -残留停止超滤,收集截留液; The step (3) is to replace the ultrafiltration system with a 3kd ultrafiltration membrane package, test the air tightness after installation, adjust the peristaltic pump rotational speed to a certain flow rate after passing the test, and adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements. , start ultrafiltration, replenish water after ultrafiltration to a certain volume remaining, detect the filtrate through the end until there is no Cl - residue, stop ultrafiltration, and collect the retentate;所述步骤(4)为,将超滤系统更换为10kd超滤膜包,安装好后测试气密性,合格后调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合 要求,开始超滤并收集透过液,超滤至一定体积后补水3~6次,然后合并收集所有透过液;The step (4) is to replace the ultrafiltration system with a 10kd ultrafiltration membrane package, test the air tightness after installation, adjust the peristaltic pump rotational speed to a certain flow rate after passing the test, and adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements. , start ultrafiltration and collect the permeate, add water 3 to 6 times after ultrafiltration to a certain volume, and then combine and collect all permeate;所述步骤(5)为,将超滤系统更换为3kd超滤膜包,安装好后测试气密性,合格后调整蠕动泵转速至一定流速,调整进口及出口压力,使跨膜压符合要求,开始超滤,超滤至剩余一定体积后停止,放出截留液,少量水冲洗膜包及管路,与截留液合并收集进行冷冻干燥。The step (5) is to replace the ultrafiltration system with a 3kd ultrafiltration membrane package, test the air tightness after installation, adjust the peristaltic pump rotational speed to a certain flow rate after passing the test, and adjust the inlet and outlet pressures to make the transmembrane pressure meet the requirements. , start ultrafiltration, stop after ultrafiltration to a certain volume remaining, release the retentate, rinse the membrane package and pipeline with a small amount of water, and combine with the retentate to collect for freeze-drying.
- 根据权利要求4所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,使用30kd膜包超滤时蠕动泵流速为1~5L/min,10kd膜包超滤时蠕动泵流速为1~5L/min,3kd膜包超滤时蠕动泵流速为3~10L/min。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 4, wherein the flow rate of the peristaltic pump is 1 to 5L/min when using the 30kd membrane package for ultrafiltration, and the 10kd membrane package The flow rate of peristaltic pump is 1-5L/min during ultrafiltration, and the flow rate of peristaltic pump is 3-10L/min during ultrafiltration with 3kd membrane.
- 根据权利要求5所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,使用30kd膜包超滤时蠕动泵流速为2~3.5L/min,10kd膜包超滤时蠕动泵流速为2~3.5L/min,3kd膜包超滤时蠕动泵流速为4~7L/min。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 5, wherein the peristaltic pump flow rate is 2-3.5L/min when using 30kd membrane-packed ultrafiltration, and the 10kd membrane The flow rate of the peristaltic pump is 2-3.5L/min during the ultrafiltration of the membrane, and the flow rate of the peristaltic pump is 4-7L/min during the ultrafiltration of the 3kd membrane.
- 根据权利要求5所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,超滤过程中跨膜压为0.8~1.2bar,进口压为1.0~1.5bar,出口压为0.6~0.9bar。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 5, wherein in the ultrafiltration process, the transmembrane pressure is 0.8-1.2 bar, and the inlet pressure is 1.0-1.5 bar , the outlet pressure is 0.6 ~ 0.9bar.
- 根据权利要求5所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,3kd膜包超滤过程中,截留液体积为超滤前总体积的1/5~1/10时开始补水,补水体积为超滤前总体积的1/5~1/10,补水次数为5~10次。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 5, wherein in the 3kd membrane-encapsulated ultrafiltration process, the volume of the retentate is 1/1 of the total volume before ultrafiltration Start to replenish water at 5-1/10, the replenishment volume is 1/5 to 1/10 of the total volume before ultrafiltration, and the number of replenishment is 5 to 10 times.
- 根据权利要求5所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,所述步骤(3)通过AgNO 3检测透过端滤液直至无Cl -残留停止超滤。 The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 5, wherein in the step ( 3 ), the filtrate through the end is detected by AgNO until no Cl- remains. Ultrafiltration.
- 根据权利要求5所述的使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法,其特征在于,冷冻干燥后产品的重均分子量Mw为3000~10000Da。The method for purifying low-molecular-weight fucosylated glycosaminoglycans using tangential flow ultrafiltration according to claim 5, wherein the weight-average molecular weight Mw of the freeze-dried product is 3000-10000 Da.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNPCT/CN2020/117367 | 2020-09-24 | ||
CN2020117367 | 2020-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022062011A1 true WO2022062011A1 (en) | 2022-03-31 |
Family
ID=80846161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/122795 WO2022062011A1 (en) | 2020-09-24 | 2020-10-22 | Method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022062011A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63128001A (en) * | 1986-11-19 | 1988-05-31 | Taiho Yakuhin Kogyo Kk | Fgag and salt, production thereof and remedy for disseminated intravascular coagulation containing said fgag |
CN101735336A (en) * | 2009-11-06 | 2010-06-16 | 深圳海王药业有限公司 | Oligomeric fucosylated glycosaminoglycan and preparation method thereof |
CN103936889A (en) * | 2014-03-19 | 2014-07-23 | 苏州英诺凯生物医药科技有限公司 | Method for purification of enoxaparin by tangential flow filtration |
CN104130334A (en) * | 2014-07-18 | 2014-11-05 | 冯群力 | Method for extracting sea cucumber polysaccharide |
CN108285498A (en) * | 2017-01-10 | 2018-07-17 | 九芝堂股份有限公司 | A kind of oligosaccharide compound and preparation method thereof and purposes inhibiting intrinsic coagulation factor X multienzyme complexes |
CN109251255A (en) * | 2017-07-12 | 2019-01-22 | 中国海洋大学 | A kind of novel fucosylated chondroitin sulfate FCShmAnd its preparation method and application |
-
2020
- 2020-10-22 WO PCT/CN2020/122795 patent/WO2022062011A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63128001A (en) * | 1986-11-19 | 1988-05-31 | Taiho Yakuhin Kogyo Kk | Fgag and salt, production thereof and remedy for disseminated intravascular coagulation containing said fgag |
CN101735336A (en) * | 2009-11-06 | 2010-06-16 | 深圳海王药业有限公司 | Oligomeric fucosylated glycosaminoglycan and preparation method thereof |
CN103936889A (en) * | 2014-03-19 | 2014-07-23 | 苏州英诺凯生物医药科技有限公司 | Method for purification of enoxaparin by tangential flow filtration |
CN104130334A (en) * | 2014-07-18 | 2014-11-05 | 冯群力 | Method for extracting sea cucumber polysaccharide |
CN108285498A (en) * | 2017-01-10 | 2018-07-17 | 九芝堂股份有限公司 | A kind of oligosaccharide compound and preparation method thereof and purposes inhibiting intrinsic coagulation factor X multienzyme complexes |
CN109251255A (en) * | 2017-07-12 | 2019-01-22 | 中国海洋大学 | A kind of novel fucosylated chondroitin sulfate FCShmAnd its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4872983A (en) | Biocompatible cellulose dialysis membrane with increased adsorption of beta-2-microglobulin | |
CN103275246B (en) | A kind of nadroparin calcium production method | |
US4909942A (en) | Process for removing pyrogens | |
CN102731683A (en) | Method of separating natural low molecular heparin from heparin waste liquor | |
CN103232558B (en) | Preparation method of high-quality low-molecular weight dalteparin sodium | |
KR102206963B1 (en) | Method of purifying a biological material of interest in a sample using nanofiber ultrafiltration membranes operated in tangential flow filtration mode | |
BR112013010286A2 (en) | "METHOD, STARCH HYDROLYSATE AND USE OF STARCH HYDROLYSATE" | |
US20220112315A1 (en) | Method for Obtaining Low Molecular Weight Heparins by Tangential Flow Filtration | |
CN103342761A (en) | Technology for preparing enoxaparin sodium by membrane separation | |
WO2022062011A1 (en) | Method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration | |
US5110918A (en) | Process for preparing EDTA-free heparins, heparin fractions and fragments | |
WO2020010534A1 (en) | Fucosylated chondroitin sulfate oligosaccharides and rapid preparation method thereof | |
NO834346L (en) | PROCEDURE FOR CLEANING AND FRACTIONING HEPARIN | |
CN114249843A (en) | Method for purifying low molecular weight fucosylated glycosaminoglycan by using tangential flow ultrafiltration | |
CN111195485B (en) | Preparation method of polyvinyl chloride blood purification membrane | |
CN106422822A (en) | Surface heparinization hemodialysis film and preparation method thereof | |
CN101851298B (en) | Sulfated galactan and preparation method thereof | |
JPH06319968A (en) | Dialyzing membrane for blood dialysis | |
EP0438903B1 (en) | Dextrin derivatives and their use in the treatment of poisoning | |
CN103145880B (en) | Method for removing free sulphur in enoxaparin sodium raw material | |
BR112021007488A2 (en) | process to carry out the separation of an operative material and process to carry out the fractionation of gaseous feed material | |
JPH02211228A (en) | Biocompatible dialysis membrane for use in hemodialysis | |
CN112851833B (en) | Purification method for reducing protein content in sodium hyaluronate and derivatives thereof | |
CN105418805A (en) | Enoxaparin sodium purifying method | |
CN1431225A (en) | Sulfating cellulose and its preparing method as well as application in preparing anti coagulant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20954857 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20954857 Country of ref document: EP Kind code of ref document: A1 |